CDK12 and cancer: In Case 3, a CDK12 variant was detected in all cells of Regions A and B; whereas, four variants in ATRX, BRCA2, PIK3CA, and PPARG were detected specifically in Region A. All four variants displayed low VAFs (0.05–0.07), indicating a late molecular event present in a small subset of cancer cells.